Heart failure
About 500,000 people in France people suffer heart failure (HF). In Europe the figure is six million and the same in the USA.
POCT
Norway leads in POCT quality control
Increasing demand for Point of Care Testing (POCT) devices leads to an increasing number of nurses and physicians working with unfamiliar equipment. Laboratory-quality test results are available in doctor’s surgeries, out-patient clinics and hospital departments. However, how can a high and comparable quality standard for POCT be guaranteed?
Milestone for Hemo Control Haemoglobin Analyser
EKF Diagnostics has recently marked the production at its manufacturing facility in Barleben, Germany, of the 33,333rd Hemo Control, its globally successful haemoglobin point-of-care analyser, since its launch in 2003.
Point of care testing
Demand is increasing for point of care (POC) diagnostic testing, particularly for tests that help foster clinical decision-making within 30 minutes or less.
EKF Diagnostics launches new molecular division
EKF Diagnostics, worldwide manufacturer of point-of-care diagnostic tools, organ injury biomarkers and assays, has announced the launch of a new division to focus on molecular and companion diagnostics.
POCT testing technology
Julian Baines, Group CEO of EKF Diagnostics Holdings plc, considers the present role of point of-care tests and their potential value to health services
Article • Close to the patient
Focus on POCT
Bringing diagnostics to the patient: Point-of-Care-Testing (POCT) is all about examinations close to the patient – in the hospital ward, at the GP, in the ambulance or even in the patient's home. Keep reading for new developments and applications from rapid medical laboratory tests to mobile imaging solutions.
